Skeletal and hepatic changes induced by chronic vitamin A supplementation in cats

Survey of the feeding management of giant anteaters (Myrmecophaga tridactyla) and tamanduas (Tamandua tetradactyla) in the EAZA ex-situ programme

Feeding giant anteaters and tamanduas as insectivorous species provides a lot of challenges for zoological institutions. In the last decades an in-house mixture, called 'Dortmund mixture', was the most common feed used in giant anteaters and tamanduas in many countries within the European Association of Zoos and Aquaria ex-situ Programme (EEP). Some nutritional problems occurred due to imbalances in the diets. The more recent nutritional recommendations for both species advise an adapted and balanced complete feed formulated for insectivorous species due to different problems arising with an in-house mixed feed as Dortmund mixture. To objectify the present situation a questionnaire was designed and sent out to 78 institutions of the EEPs for giant anteater(s) and tamandua(s). The questionnaire was divided into different sections and asked for data on husbandry, health status, feeding, especially feed composition, feed supplementation and faecal consistency. It was completed by 45 institutions with data for 130 animals, 89 giant anteaters and 41 tamanduas. The data thus represent 54% and 59% of the EEP populations. For both species, a complete feed is mainly utilised. Especially institutions that have integrated anteaters and tamanduas into their facilities during the last 10 and 20 years, use a complete feed. Regarding the in-house mixtures, there are distinct differences, both in composition and amount of each ingredient used. The evaluation of the feeds used for enrichment, for example, shows a clear species difference. While in tamanduas mainly insects are used for this purpose, in giant anteaters it is mainly fruits and avocado. In contrast to the past, many anteaters today are fed an adapted complete feed. Surprisingly, concerning feeding supplements the use of fat-soluble vitamins and combined vitamin-mineral preparations is still common in both species. More effort needs to be put into enforcing current feeding recommendations, especially for the giant anteaters.

Drug-induced liver injury and prospect of cytokine based therapy; A focus on IL-2 based therapies

Drug-induced liver injury (DILI) is one of the most frequent sources of liver failure and the leading cause of liver transplant. Common non-prescription medications such as non-steroidal anti-inflammatory drugs (NSAIDs), acetaminophen, and other prescription drugs when taken at more than the recommended doses may lead to DILI. The severity of DILI is affected by factors such as age, ethnicity, race, gender, nutritional status, on-going liver diseases, renal function, pregnancy, alcohol consumption, and drug-drug interactions. Characteristics of DILI-associated inflammation include apoptosis and necrosis of hepatocytes and hepatic infiltration of pro-inflammatory immune cells. If untreated or if the inflammation continues, DILI and associated hepatic inflammation may lead to development of hepatocarcinoma. The therapeutic approach for DILI-associated hepatic inflammation depends on whether the inflammation is acute or chronic. Discontinuing the causative medication, vaccination, and special dietary supplementation are some of the conventional approaches to treat DILI. In this review, we discuss a concise overview of DILI-associated liver complications, and current therapeutic options with special emphasis on biologics including the scope of cytokine therapy in hepatic repair and resolution of inflammation caused by over- the-counter (OTC) or prescription drugs.

Calcium, Phosphorus, and Vitamin D in Dogs and Cats: Beyond the Bones

Calcium, phosphorus, and vitamin D are nutrients that play a key role in maintaining normal organ, cell, and tissue function. Much is known about their role in bone metabolism, but these nutrients are also important in renal health, urinary tract disease, and multiple other organ systems. It is nutritionally important to meet the physiologic requirements for each of these nutrients, but the interplay between them should also be considered.

Gene expressions of de novo hepatic lipogenesis in feline hepatic lipidosis

Objectives

The aim of this study was to evaluate if de novo hepatic lipid synthesis contributes to fatty acid overload in the liver of cats with feline hepatic lipidosis (FHL).

Methods

Lipogenic gene expression of peroxisome proliferator-activated receptor-alpha (PPAR-α), peroxisome proliferator-activated receptor-gamma (PPAR-γ), fatty acid synthase (FASN) and sterol regulatory element-binding factor (SREBF1) were evaluated using quantitative RT-PCR in liver tissue of six cats with FHL and compared with the liver tissue of eight healthy cats.

Results

In liver tissue, PPAR-α, PPAR-γ and FASN mRNA expression levels were not significantly different (P >0.12, P >0.89 and P >0.5, respectively) in the FHL group compared with the control group. SREBF1 gene expression was downregulated around 10-fold in the FHL group vs the control group (P = 0.039).

Conclusions and relevance

The downregulation of SREBF1 in the liver tissue of cats with FHL does not support the hypothesis that de novo lipogenesis in the liver is an important pathway of fatty acid accumulation in FHL.